These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. The novel hypoglycemic agent YM440 normalizes hyperglycemia without changing body fat weight in diabetic db/db mice. Shimaya A; Kurosaki E; Nakano R; Hirayama R; Shibasaki M; Shikama H Metabolism; 2000 Mar; 49(3):411-7. PubMed ID: 10726922 [TBL] [Abstract][Full Text] [Related]
9. Troglitazone ameliorates insulin resistance in a diabetic patient with Prader-Willi syndrome. Yamakita T; Ishii T; Mori T; Yoshioka K; Sato T; Tanaka S; Kurimasa H; Fujita K; Fujii S Diabetes Res Clin Pract; 1998 Dec; 42(3):205-8. PubMed ID: 9925352 [TBL] [Abstract][Full Text] [Related]
10. Effect of troglitazone on insulin sensitivity and pancreatic beta-cell function in women at high risk for NIDDM. Berkowitz K; Peters R; Kjos SL; Goico J; Marroquin A; Dunn ME; Xiang A; Azen S; Buchanan TA Diabetes; 1996 Nov; 45(11):1572-9. PubMed ID: 8866563 [TBL] [Abstract][Full Text] [Related]
11. Impaired glucose tolerance is normalized by treatment with the thiazolidinedione troglitazone. Antonucci T; Whitcomb R; McLain R; Lockwood D; Norris RM Diabetes Care; 1997 Feb; 20(2):188-93. PubMed ID: 9118772 [TBL] [Abstract][Full Text] [Related]
13. Troglitazone and related compounds: therapeutic potential beyond diabetes. Fujiwara T; Horikoshi H Life Sci; 2000 Oct; 67(20):2405-16. PubMed ID: 11065164 [TBL] [Abstract][Full Text] [Related]
14. Troglitazone and small low-density lipoprotein in type 2 diabetes. Hirano T; Yoshino G; Kazumi T Ann Intern Med; 1998 Jul; 129(2):162-3. PubMed ID: 9669982 [No Abstract] [Full Text] [Related]
15. Pregnancy after treatment with the insulin-sensitizing agent troglitazone in an obese woman with the hyperandrogenic, insulin-resistant acanthosis nigricans syndrome. Elkind-Hirsch KE; McWilliams RB Fertil Steril; 1999 May; 71(5):943-7. PubMed ID: 10231062 [TBL] [Abstract][Full Text] [Related]
16. Troglitazone, an insulin action enhancer, improves glycaemic control and insulin sensitivity in elderly type 2 diabetic patients. Kumar S; Prange A; Schulze J; Lettis S; Barnett AH Diabet Med; 1998 Sep; 15(9):772-9. PubMed ID: 9737807 [TBL] [Abstract][Full Text] [Related]
18. Thiazolidinediones for type 2 diabetes. New agents reduce insulin resistance but need long term clinical trials. Krentz AJ; Bailey CJ; Melander A BMJ; 2000 Jul; 321(7256):252-3. PubMed ID: 10915108 [No Abstract] [Full Text] [Related]
19. Troglitazone decreases serum uric acid concentrations in type II diabetic patients and non-diabetics. Iwatani M; Wasada T; Katsumori K; Watanabe-Takahashi C; Kamatani N; Iwamoto Y Diabetologia; 2000 Jun; 43(6):814-5. PubMed ID: 10907128 [No Abstract] [Full Text] [Related]
20. New directions in treating insulin resistance. Reusch JE Hosp Pract (1995); 1995 Sep; 30(9):9-10. PubMed ID: 7559840 [No Abstract] [Full Text] [Related] [Next] [New Search]